1. Market Research
  2. > M's Science Corporation - Product Pipeline Review - 2013

M's Science Corporation - Product Pipeline Review - 2013

  • June 2013
  • -
  • Global Markets Direct
  • -
  • 22 pages

M's Science Corporation - Product Pipeline Review - 2013


Summary


Global Market Direct’s pharmaceuticals report, “M's Science Corporation - Product Pipeline Review - 2013” provides data on the M's Science Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, M's Science Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from M's Science Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.


Scope


- M's Science Corporation - Brief M's Science Corporation overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of M's Science Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of M's Science Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the M's Science Corporation’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.


Reasons to buy


- Evaluate M's Science Corporation’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of M's Science Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the M's Science Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with M's Science Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of M's Science Corporation and identify potential opportunities in those areas.

Table Of Contents

M's Science Corporation - Product Pipeline Review - 2013
Table of Contents 2
List of Tables 3
List of Figures 3
M's Science Corporation Snapshot 4
M's Science Corporation Overview 4
Key Information 4
Key Facts 4
M's Science Corporation - Research and Development Overview 5
Key Therapeutic Areas 5
M's Science Corporation - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
M's Science Corporation - Pipeline Products Glance 10
M's Science Corporation Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
M's Science Corporation - Early Stage Pipeline Products 12
Pre-Clinical Products/Combination Treatment Modalities 12
M's Science Corporation - Drug Profiles 13
cutamesine 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
MC-116 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
M's Science Corporation - Pipeline Analysis 16
M's Science Corporation - Pipeline Products by Therapeutic Class 16
M's Science Corporation - Pipeline Products by Route of Administration 17
M's Science Corporation - Pipeline Products By Mechanism of Action 18
M's Science Corporation - Dormant Projects 19
M's Science Corporation - Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
Coverage 21
Secondary Research 21
Primary Research 21
Expert Panel Validation 21
Contact Us 22
Disclaimer 22

List of Tables


M's Science Corporation, Key Information 4
M's Science Corporation, Key Facts 4
M's Science Corporation - Pipeline by Indication, 2013 7
M's Science Corporation - Pipeline by Stage of Development, 2013 8
M's Science Corporation - Monotherapy Products in Pipeline, 2013 9
M's Science Corporation - Phase II, 2013 10
M's Science Corporation - Phase I, 2013 11
M's Science Corporation - Pre-Clinical, 2013 12
M's Science Corporation - Pipeline By Therapeutic Class, 2013 16
M's Science Corporation - Pipeline By Route of Administration, 2013 17
M's Science Corporation - Pipeline Products By Mechanism of Action, 2013 18
M's Science Corporation - Dormant Developmental Projects,2013 19

List of Figures


M's Science Corporation - Pipeline by Indication, 2013 6
M's Science Corporation - Pipeline by Stage of Development, 2013 8
M's Science Corporation - Monotherapy Products in Pipeline, 2013 9
M's Science Corporation - Pipeline By Therapeutic Class, 2013 16

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.